top of page
Impavido® (miltefosine) is an FDA-approved treatment for cutaneous, mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO
SITE IS MEANT FOR HEALTHCARE PROFESSIONALS ONLY
*U.S. residents only
®
Profile
Join date: Feb 23, 2026
About
0Â likes received
0Â comments received
0Â best answers
The Future of Offshore Development Teams depends on managers leading by example. See how creating a safe space for mistakes fosters true innovation today.
Oscorm
Future of Offshore Development Teams
More actions
bottom of page